A
Price
$119.42
Change
+$0.80 (+0.67%)
Updated
Jun 26 closing price
Capitalization
42.66B
53 days until earnings call
NOTV
Price
$1.84
Change
+$0.03 (+1.66%)
Updated
Jun 26 closing price
Capitalization
254.55M
40 days until earnings call
Interact to see
Advertisement

A vs NOTV

Header iconA vs NOTV Comparison
Open Charts A vs NOTVBanner chart's image
Agilent Technologies
Price$119.42
Change+$0.80 (+0.67%)
Volume$1.49M
Capitalization42.66B
Inotiv
Price$1.84
Change+$0.03 (+1.66%)
Volume$222.38K
Capitalization254.55M
A vs NOTV Comparison Chart in %
Loading...
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NOTV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
A vs. NOTV commentary
Jun 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is A is a Buy and NOTV is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 27, 2025
Stock price -- (A: $119.42 vs. NOTV: $1.84)
Brand notoriety: A and NOTV are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: A: 72% vs. NOTV: 35%
Market capitalization -- A: $42.66B vs. NOTV: $254.55M
A [@Medical Specialties] is valued at $42.66B. NOTV’s [@Medical Specialties] market capitalization is $254.55M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.56B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

A’s FA Score shows that 1 FA rating(s) are green whileNOTV’s FA Score has 0 green FA rating(s).

  • A’s FA Score: 1 green, 4 red.
  • NOTV’s FA Score: 0 green, 5 red.
According to our system of comparison, A is a better buy in the long-term than NOTV.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

A’s TA Score shows that 6 TA indicator(s) are bullish while NOTV’s TA Score has 3 bullish TA indicator(s).

  • A’s TA Score: 6 bullish, 4 bearish.
  • NOTV’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, A is a better buy in the short-term than NOTV.

Price Growth

A (@Medical Specialties) experienced а +3.38% price change this week, while NOTV (@Medical Specialties) price change was -15.21% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.93%. For the same industry, the average monthly price growth was +0.51%, and the average quarterly price growth was +0.02%.

Reported Earning Dates

A is expected to report earnings on Aug 19, 2025.

NOTV is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Medical Specialties (+0.93% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
A($42.7B) has a higher market cap than NOTV($255M). NOTV has higher P/E ratio than A: NOTV (169.49) vs A (34.82). A YTD gains are higher at: -10.917 vs. NOTV (-55.556). A has higher annual earnings (EBITDA): 1.69B vs. NOTV (59M). NOTV has less debt than A: NOTV (429M) vs A (2.56B). A has higher revenues than NOTV: A (6.74B) vs NOTV (585M).
ANOTVA / NOTV
Capitalization42.7B255M16,745%
EBITDA1.69B59M2,864%
Gain YTD-10.917-55.55620%
P/E Ratio34.82169.4921%
Revenue6.74B585M1,151%
Total CashN/A22M-
Total Debt2.56B429M596%
FUNDAMENTALS RATINGS
A vs NOTV: Fundamental Ratings
A
NOTV
OUTLOOK RATING
1..100
1361
VALUATION
overvalued / fair valued / undervalued
1..100
20
Undervalued
89
Overvalued
PROFIT vs RISK RATING
1..100
66100
SMR RATING
1..100
4797
PRICE GROWTH RATING
1..100
5565
P/E GROWTH RATING
1..100
6474
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

A's Valuation (20) in the Biotechnology industry is significantly better than the same rating for NOTV (89) in the Servicestothe Health Industry industry. This means that A’s stock grew significantly faster than NOTV’s over the last 12 months.

A's Profit vs Risk Rating (66) in the Biotechnology industry is somewhat better than the same rating for NOTV (100) in the Servicestothe Health Industry industry. This means that A’s stock grew somewhat faster than NOTV’s over the last 12 months.

A's SMR Rating (47) in the Biotechnology industry is somewhat better than the same rating for NOTV (97) in the Servicestothe Health Industry industry. This means that A’s stock grew somewhat faster than NOTV’s over the last 12 months.

A's Price Growth Rating (55) in the Biotechnology industry is in the same range as NOTV (65) in the Servicestothe Health Industry industry. This means that A’s stock grew similarly to NOTV’s over the last 12 months.

A's P/E Growth Rating (64) in the Biotechnology industry is in the same range as NOTV (74) in the Servicestothe Health Industry industry. This means that A’s stock grew similarly to NOTV’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ANOTV
RSI
ODDS (%)
Bearish Trend 1 day ago
53%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
58%
Bullish Trend 1 day ago
82%
Momentum
ODDS (%)
Bearish Trend 1 day ago
57%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bullish Trend 1 day ago
66%
Bearish Trend 1 day ago
80%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
64%
Bearish Trend 1 day ago
85%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
61%
Bearish Trend 1 day ago
87%
Advances
ODDS (%)
Bullish Trend 1 day ago
61%
Bullish Trend 24 days ago
88%
Declines
ODDS (%)
Bearish Trend 10 days ago
60%
Bearish Trend 3 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
57%
Bearish Trend 1 day ago
76%
Aroon
ODDS (%)
Bullish Trend 1 day ago
61%
Bullish Trend 1 day ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NOTV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FCUCX18.920.09
+0.48%
NYLI PineStone U.S. Equity Class C
PNOPX121.63N/A
N/A
Putnam Sustainable Leaders A
HBFBX12.09N/A
N/A
Hennessy Balanced Investor
TCPWX13.19N/A
N/A
Transamerica Capital Growth R6
TARKX29.04N/A
N/A
Tarkio

NOTV and

Correlation & Price change

A.I.dvisor indicates that over the last year, NOTV has been loosely correlated with CRL. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if NOTV jumps, then CRL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NOTV
1D Price
Change %
NOTV100%
+1.66%
CRL - NOTV
58%
Loosely correlated
+0.92%
IQV - NOTV
46%
Loosely correlated
-0.35%
A - NOTV
42%
Loosely correlated
+0.67%
MEDP - NOTV
42%
Loosely correlated
-1.39%
TWST - NOTV
42%
Loosely correlated
-0.14%
More